Prostate cancer early warning protein detected

Professor Foster: "We now need to define the role this protein is playing in prostate cancer"

(Medical Xpress) -- Scientists at the University have discovered a protein, only present in prostate cancer cells, that could be used as a marker to detect early signs of the disease.     

Published in the British Journal of Cancer, the research examines a unique sequence of a gene that produces a in , which may be linked to aggressive forms of the disease.  The findings could contribute to future drug development programmes for those patients who are currently untreatable. 

Professor Chris Foster, from the University’s Institute of Translational Medicine, had previously shown that the gene, called PRKCZ, controls the aggressive behaviour of cells.  He has now discovered that this gene changes its expression in prostate and produces a protein that could be responsible for changing the behaviour of the cells.  This means that the protein could be used as a potential marker for the disease, indicating which patients are at risk of developing a more aggressive type of cancer.

Reducing effect of cancer cells

Professor Foster said: “We know that the protein produced by the altered gene contains a unique active region. We now need to define the role that this protein is playing in prostate cancer. If it encourages aggressiveness in prostate cancers then we may be able to develop new drugs that reduce its effects in the cancer cells.”

Prostate cancer is the most common cancer in men. Each year approximately 40,800 men are diagnosed with prostate cancer in the UK and around 10,700 die from the disease. The findings of this study may provide a biological approach to treating men with aggressive forms of prostate cancer and for whom no specific therapy is currently available.

The study is supported by Cancer Research UK and the North West Cancer Research Fund.

add to favorites email to friend print save as pdf

Related Stories

Womb cancer genome scan reveals prostate cancer link

Apr 18, 2011

The first genome scan for womb cancer has revealed a genetic region that is associated with a reduced risk of the disease. The same region, called HNF1B, has been linked previously to lower prostate cancer risk in men.

Vitamin D levels, prostate cancer not linked

Feb 14, 2011

(PhysOrg.com) -- In a detailed review, funded by Cancer Research UK, scientists looked at all the available evidence and found there was no link between the amount of vitamin D in men’s blood and the ...

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

8 hours ago

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

12 hours ago

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.